The stiffness associated with cardiac fibrosis activates the expression of a common genetic polymorphism associated with cardiac pathology.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$99.00 per year
only $8.25 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Yusuf, S. et al. Lancet 364, 937–952 (2004).
Kathiresan, S. & Srivastava, D. Cell 148, 1242–1257 (2012).
Nielsen, J. B. et al. Nat. Genet. 50, 1234–1239 (2018).
Haas, J. et al. EMBO Mol. Med. 10, 107–120 (2018).
Wellcome Trust Case Control Consortium. Nature 447, 661–678 (2007).
Kumar, A. et al. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-018-0344-5 (2019).
Congrains, A., Kamide, K., Ohishi, M. & Rakugi, H. Int. J. Mol. Sci. 14, 1278–1292 (2013).
Helgadottir, A. et al. Science 316, 1491–1493 (2007).
Lo Sardo, V. et al. Cell 175, 1796–1810 (2018).
Lian, X. et al. Nat. Protocols 8, 162–175 (2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
T.J. Herron is a co-founder of CARTOX, LLC, a biotechnology company focused on using hiPSC-CMs for preclinical cardiotoxicity screening.
Rights and permissions
About this article
Cite this article
Herron, T.J. Stiffness triggers non-coding RNA pathology. Nat Biomed Eng 3, 85–86 (2019). https://doi.org/10.1038/s41551-019-0352-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41551-019-0352-0